These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1074 related items for PubMed ID: 14508836

  • 1. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB.
    Cancer; 2003 Oct 01; 98(7):1483-90. PubMed ID: 14508836
    [Abstract] [Full Text] [Related]

  • 2. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF.
    Eur J Surg Oncol; 2000 Nov 01; 26(7):669-78. PubMed ID: 11078614
    [Abstract] [Full Text] [Related]

  • 3. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Kroon BB.
    Arch Surg; 2004 Nov 01; 139(11):1237-42. PubMed ID: 15545572
    [Abstract] [Full Text] [Related]

  • 4. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB.
    Eur J Surg Oncol; 2006 Apr 01; 32(3):318-24. PubMed ID: 16412605
    [Abstract] [Full Text] [Related]

  • 5. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
    Cherix S, Speiser M, Matter M, Raffoul W, Liénard D, Theumann N, Mouhsine E, Mirimanoff RO, Leyvraz S, Lejeune FJ, Leyvraz PF.
    J Surg Oncol; 2008 Sep 01; 98(3):148-55. PubMed ID: 18668638
    [Abstract] [Full Text] [Related]

  • 6. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
    Thijssens KM, van Ginkel RJ, Pras E, Suurmeijer AJ, Hoekstra HJ.
    Ann Surg Oncol; 2006 Apr 01; 13(4):518-24. PubMed ID: 16485147
    [Abstract] [Full Text] [Related]

  • 7. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
    Grunhagen DJ, de Wilt JH, Graveland WJ, Verhoef C, van Geel AN, Eggermont AM.
    Cancer; 2006 Apr 15; 106(8):1776-84. PubMed ID: 16541435
    [Abstract] [Full Text] [Related]

  • 8. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB, Vrouenraets BC, van Geel AN, Nieweg OE, Noorda EM, Eggermont AM, Kroon BB.
    J Surg Oncol; 2005 Aug 01; 91(2):107-11. PubMed ID: 16028280
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
    Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, Verhoef C.
    J Clin Oncol; 2011 Oct 20; 29(30):4036-44. PubMed ID: 21931039
    [Abstract] [Full Text] [Related]

  • 10. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F, Giacomini P, Rossi CR, Santinami M, Garinei R, Anzà M, Deraco M, Botti C, Perri P, Cavaliere F, Di Angelo P, Sofra C, Sperduti I, Pasqualoni R, Di Filippo S, Corrias F, Armenti A, Ferraresi V.
    In Vivo; 2009 Oct 20; 23(2):363-7. PubMed ID: 19414428
    [Abstract] [Full Text] [Related]

  • 11. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.
    Grünhagen DJ, de Wilt JH, Verhoef C, van Geel AN, Eggermont AM.
    Eur J Surg Oncol; 2005 Oct 20; 31(8):912-6. PubMed ID: 16098709
    [Abstract] [Full Text] [Related]

  • 12. Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.
    Lans TE, Grünhagen DJ, de Wilt JH, van Geel AN, Eggermont AM.
    Ann Surg Oncol; 2005 May 20; 12(5):406-11. PubMed ID: 15915375
    [Abstract] [Full Text] [Related]

  • 13. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.
    Bickels J, Manusama ER, Gutman M, Eggermont AM, Kollender Y, Abu-Abid S, Van Geel AN, Lev-Shlush D, Klausner JM, Meller I.
    Eur J Surg Oncol; 1999 Oct 20; 25(5):509-14. PubMed ID: 10527599
    [Abstract] [Full Text] [Related]

  • 14. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM, Vrouenraets BC, van Geel BN, Eggermont AM, Klaase JM, Nieweg OE, Kroon BB.
    J Am Coll Surg; 1996 Jun 20; 182(6):467-72. PubMed ID: 8646345
    [Abstract] [Full Text] [Related]

  • 15. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient.
    Bonvalot S, Rimareix F, Causeret S, Le Péchoux C, Boulet B, Terrier P, Le Cesne A, Muret J.
    Ann Surg Oncol; 2009 Dec 20; 16(12):3350-7. PubMed ID: 19830495
    [Abstract] [Full Text] [Related]

  • 16. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
    Alegre JF, Duarte M, Sureda González M, Bretcha Boix P, Dussan C, Ballester A, Crespo A, Brugarolas Masllorens A.
    Cir Esp; 2012 Feb 20; 90(2):114-20. PubMed ID: 22225611
    [Abstract] [Full Text] [Related]

  • 17. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM.
    Ann Surg Oncol; 2007 Jan 20; 14(1):230-8. PubMed ID: 17066234
    [Abstract] [Full Text] [Related]

  • 18. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
    Vrouenraets BC, Eggermont AM, Hart AA, Klaase JM, van Geel AN, Nieweg OE, Kroon BB.
    Eur J Surg Oncol; 2001 Jun 20; 27(4):390-5. PubMed ID: 11417986
    [Abstract] [Full Text] [Related]

  • 19. Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.
    Eggermont AM, Schraffordt Koops H, Klausner JM, Liénard D, Kroon BB, Schlag PM, Ben-Ari G, Lejeune FJ.
    Semin Oncol; 1997 Oct 20; 24(5):547-55. PubMed ID: 9344321
    [Abstract] [Full Text] [Related]

  • 20. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
    Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Liénard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC, Lejeune FJ.
    Ann Surg; 1996 Dec 20; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.